These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8509435)

  • 1. The EnDA endometrial adenocarcinoma: an oestrogen-sensitive, metastasizing, in vivo tumour model of the rat.
    Horn DW; Vollmer G; Deerberg F; Schneider MR
    J Cancer Res Clin Oncol; 1993; 119(8):450-6. PubMed ID: 8509435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the nonsteroidal antiestrogen ZK 119.010 on growth and metastasis of the EnDA endometrial carcinoma.
    Horn DW; Vollmer G; von Angerer E; Schneider MR
    Int J Cancer; 1994 Aug; 58(3):426-9. PubMed ID: 8050824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rat endometrial adenocarcinoma cell line RUCA-I: a novel hormone-responsive in vivo/in vitro tumor model.
    Vollmer G; Schneider MR
    J Steroid Biochem Mol Biol; 1996 Apr; 58(1):103-15. PubMed ID: 8809192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a preclinical model for hormonal therapy of human endometrial carcinomas.
    Satyaswaroop PG
    Ann Med; 1993 Apr; 25(2):105-11. PubMed ID: 8489746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functions of estrogens and anti-estrogens in the rat endometrial adenocarcinoma cell lines RUCA-I and RUCA-II.
    Schütze N; Kraft V; Deerberg F; Winking H; Meitinger D; Ebert K; Knuppen R; Vollmer G
    Int J Cancer; 1992 Dec; 52(6):941-9. PubMed ID: 1459735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant administration of an isopropanolic extract of black cohosh and tamoxifen in the in vivo tumor model of implanted RUCA-I rat endometrial adenocarcinoma cells.
    Nisslein T; Freudenstein J
    Toxicol Lett; 2004 May; 150(3):271-5. PubMed ID: 15110078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal therapy of human endometrial adenocarcinoma in a nude mouse model.
    Zaino RJ; Satyaswaroop PG; Mortel R
    Cancer Res; 1985 Feb; 45(2):539-41. PubMed ID: 3967228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estradiol induced changes in tumor growth and steroid receptor content in a heterotransplanted human endometrial adenocarcinoma.
    Horvath G; Fernö M; Baldetorp B; Cameron R; Ranstam J
    In Vivo; 1991; 5(4):401-6. PubMed ID: 1810429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phytoestrogens and carcinogenesis-differential effects of genistein in experimental models of normal and malignant rat endometrium.
    Diel P; Smolnikar K; Schulz T; Laudenbach-Leschowski U; Michna H; Vollmer G
    Hum Reprod; 2001 May; 16(5):997-1006. PubMed ID: 11331651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-deficient animals to study "hormone-dependent" breast and endometrial cancer.
    Jordan VC; Gottardis MM; Robinson SP; Friedl A
    J Steroid Biochem; 1989; 34(1-6):169-76. PubMed ID: 2626014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen exerts oestrogen-agonistic effects on proliferation and plasminogen activation, but not on gelatinase activity, glycogen metabolism and p53 protein expression, in cultures of oestrogen-responsive human endometrial adenocarcinoma cells.
    Hochner-Celnikier D; Greenfield C; Finci-Yeheskel Z; Milwidsky A; Gutman A; Goldman-Wohl D; Yagel S; Mayer M
    Mol Hum Reprod; 1997 Dec; 3(12):1019-27. PubMed ID: 9464846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal regulation of proliferation and transforming growth factors gene expression in human endometrial adenocarcinoma xenografts.
    Gong Y; Murphy LC; Murphy LJ
    J Steroid Biochem Mol Biol; 1994 Jul; 50(1-2):13-9. PubMed ID: 8049128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphology, growth characteristics and oestrogen-binding capacity of DMBA-induced mammary tumours from ovariectomized rats.
    Boylan ES; Fowler EH; Wittliff JL
    Br J Cancer; 1977 May; 35(5):602-9. PubMed ID: 405032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone receptor A and B expression and progestagen treatment in growth and spread of endometrial cancer cells in nude mice.
    Hanekamp EE; Kühne LM; Grootegoed JA; Burger CW; Blok LJ
    Endocr Relat Cancer; 2004 Dec; 11(4):831-41. PubMed ID: 15613456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Growth regulation of sex steroid hormone in endometrial carcinoma transplanted into nude mice].
    Kato Y; Morisawa T; Kuramoto H
    Hum Cell; 1991 Jun; 4(2):165-70. PubMed ID: 1835653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A spontaneous estrogen dependent, tamoxifen sensitive mouse mammary tumor: a new model system to study hormone-responsiveness in immune competent mice.
    Simian M; Manzur T; Rodriguez V; de Kier Joffé EB; Klein S
    Breast Cancer Res Treat; 2009 Jan; 113(1):1-8. PubMed ID: 18183485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.
    Dardes RC; Schafer JM; Pearce ST; Osipo C; Chen B; Jordan VC
    Gynecol Oncol; 2002 Jun; 85(3):498-506. PubMed ID: 12051881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphology of human uterine cancer in nude mice. Effects of hormone and antihormone treatment.
    Zaino RJ; Satyaswaroop PG; Mortel R
    Arch Pathol Lab Med; 1984 Jul; 108(7):571-8. PubMed ID: 6547322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progestin treatment decreases CD133+ cancer stem cell populations in endometrial cancer.
    Guy MS; Qamar L; Behbakht K; Post MD; Sheeder J; Sartorius CA; Spillman MA
    Gynecol Oncol; 2016 Mar; 140(3):518-26. PubMed ID: 26731726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.